199 related articles for article (PubMed ID: 11919653)
1. Concentration-dependent stimulatory and inhibitory effect of troglitazone on insulin-induced fatty acid synthase expression and protein kinase B activity in 3T3-L1 adipocytes.
Barthel A; Krüger KD; Roth RA; Joost HG
Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):290-5. PubMed ID: 11919653
[TBL] [Abstract][Full Text] [Related]
2. Effects of troglitazone on cellular differentiation, insulin signaling, and glucose metabolism in cultured human skeletal muscle cells.
Kausch C; Krützfeldt J; Witke A; Rettig A; Bachmann O; Rett K; Matthaei S; Machicao F; Häring HU; Stumvoll M
Biochem Biophys Res Commun; 2001 Jan; 280(3):664-74. PubMed ID: 11162573
[TBL] [Abstract][Full Text] [Related]
3. Metformin reduces adiponectin protein expression and release in 3T3-L1 adipocytes involving activation of AMP activated protein kinase.
Huypens P; Quartier E; Pipeleers D; Van de Casteele M
Eur J Pharmacol; 2005 Aug; 518(2-3):90-5. PubMed ID: 16039647
[TBL] [Abstract][Full Text] [Related]
4. Lipoic acid protects against oxidative stress induced impairment in insulin stimulation of protein kinase B and glucose transport in 3T3-L1 adipocytes.
Rudich A; Tirosh A; Potashnik R; Khamaisi M; Bashan N
Diabetologia; 1999 Aug; 42(8):949-57. PubMed ID: 10491755
[TBL] [Abstract][Full Text] [Related]
5. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.
Okuno A; Tamemoto H; Tobe K; Ueki K; Mori Y; Iwamoto K; Umesono K; Akanuma Y; Fujiwara T; Horikoshi H; Yazaki Y; Kadowaki T
J Clin Invest; 1998 Mar; 101(6):1354-61. PubMed ID: 9502777
[TBL] [Abstract][Full Text] [Related]
6. SIK2 can be activated by deprivation of nutrition and it inhibits expression of lipogenic genes in adipocytes.
Du J; Chen Q; Takemori H; Xu H
Obesity (Silver Spring); 2008 Mar; 16(3):531-8. PubMed ID: 18239551
[TBL] [Abstract][Full Text] [Related]
7. 3T3-L1 adipocyte apoptosis induced by thiazolidinediones is peroxisome proliferator-activated receptor-gamma-dependent and mediated by the caspase-3-dependent apoptotic pathway.
Xiao Y; Yuan T; Yao W; Liao K
FEBS J; 2010 Feb; 277(3):687-96. PubMed ID: 20050918
[TBL] [Abstract][Full Text] [Related]
8. Role of PDK1 in insulin-signaling pathway for glucose metabolism in 3T3-L1 adipocytes.
Yamada T; Katagiri H; Asano T; Tsuru M; Inukai K; Ono H; Kodama T; Kikuchi M; Oka Y
Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1385-94. PubMed ID: 12006370
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
[TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone, an agonist of peroxisome-proliferator-activated receptor gamma (PPARgamma), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivo.
Jiang G; Dallas-Yang Q; Biswas S; Li Z; Zhang BB
Biochem J; 2004 Jan; 377(Pt 2):339-46. PubMed ID: 14556646
[TBL] [Abstract][Full Text] [Related]
11. Troglitazone induces expression of PPARgamma in liver.
Davies GF; Khandelwal RL; Roesler WJ
Mol Cell Biol Res Commun; 1999; 2(3):202-8. PubMed ID: 10662598
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor-gamma agonists modulate macrophage activation by gram-negative and gram-positive bacterial stimuli.
Guyton K; Zingarelli B; Ashton S; Teti G; Tempel G; Reilly C; Gilkeson G; Halushka P; Cook J
Shock; 2003 Jul; 20(1):56-62. PubMed ID: 12813370
[TBL] [Abstract][Full Text] [Related]
13. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
Díaz-Delfín J; Morales M; Caelles C
Diabetes; 2007 Jul; 56(7):1865-71. PubMed ID: 17416798
[TBL] [Abstract][Full Text] [Related]
14. Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: a new possible role of PPARgamma on vascular endothelial function.
Satoh H; Tsukamoto K; Hashimoto Y; Hashimoto N; Togo M; Hara M; Maekawa H; Isoo N; Kimura S; Watanabe T
Biochem Biophys Res Commun; 1999 Jan; 254(3):757-63. PubMed ID: 9920814
[TBL] [Abstract][Full Text] [Related]
15. Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues.
LeBrasseur NK; Kelly M; Tsao TS; Farmer SR; Saha AK; Ruderman NB; Tomas E
Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E175-81. PubMed ID: 16464908
[TBL] [Abstract][Full Text] [Related]
16. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
[TBL] [Abstract][Full Text] [Related]
17. Effect of troglitazone on CYP1A1 induction.
Kim HG; Han EH; Jeong HG
Toxicology; 2008 Apr; 246(2-3):166-71. PubMed ID: 18308446
[TBL] [Abstract][Full Text] [Related]
18. Thiazolidinediones (PPARgamma agonists) but not PPARalpha agonists increase IRS-2 gene expression in 3T3-L1 and human adipocytes.
Smith U; Gogg S; Johansson A; Olausson T; Rotter V; Svalstedt B
FASEB J; 2001 Jan; 15(1):215-220. PubMed ID: 11149909
[TBL] [Abstract][Full Text] [Related]
19. Effect of troglitazone on tumor necrosis factor alpha and transforming growth factor beta expression and action in human adipocyte precursor cells in primary culture.
Skurk T; Birgel M; Lee YM; Hauner H
Metabolism; 2006 Mar; 55(3):309-16. PubMed ID: 16483873
[TBL] [Abstract][Full Text] [Related]
20. Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gamma.
Young PW; Buckle DR; Cantello BC; Chapman H; Clapham JC; Coyle PJ; Haigh D; Hindley RM; Holder JC; Kallender H; Latter AJ; Lawrie KW; Mossakowska D; Murphy GJ; Roxbee Cox L; Smith SA
J Pharmacol Exp Ther; 1998 Feb; 284(2):751-9. PubMed ID: 9454824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]